#LantheusHoldings is buying #radiopharma #CDMO #EvergreenTheragnostics for $250M. #CDMOs with capabilities handling #radiopharmaceuticals are seeing strong demand, reflecting strength in these therapeutic modalities, according to CPHI's 2024 annual report.
#LantheusHoldings #radiopharma #CDMO #EvergreenTheragnostics #CDMOs #radiopharmaceuticals